Company Overview
American HealthCare Capital is pleased to introduce a CHAP-accredited hospice provider for sale serving multiple markets throughout the Western United States. This organization offers comprehensive adult and pediatric hospice and palliative care services across urban and rural regions. Established in 2020, the company has grown into one of the largest and most reputable hospice providers in the region, recognized for its compassionate, patient-centered approach and strong operational infrastructure.
Services
The company delivers a full spectrum of in-home hospice and palliative care services, supported by a 24-hour on-call nursing team and a multidisciplinary clinical staff. Care is coordinated seamlessly across hospitals, physician offices, skilled nursing facilities, and managed care providers to ensure optimal patient outcomes. The organization operates from fully accredited locations, maintaining Medicare certification and CHAP accreditation at all sites.
Census and Payer Mix
Patient volume has grown steadily, with a combined average daily census exceeding 400 patients. Approximately two-thirds of the current census is pediatric, reflecting the company’s distinctive capability in children’s hospice and palliative care. The payer mix is predominantly government-based, led by Medicare and Medicaid, with private insurance and self-pay representing a smaller segment.
Financial Overview
Financial performance has been exceptional. Combined revenue has grown from roughly $7.7 million in 2022 to $22.5 million in 2024 and is projected to exceed $28 million in 2025. Adjusted EBITDA rose from under $1 million in 2022 to approximately $8.4 million in 2024, with 2025 projections of $12 million, representing margins above 40%. Growth has been driven by strong referral relationships, expanding pediatric contracts, and disciplined cost management.
Staffing Overview
The company is supported by a seasoned executive group including a Chief Operating Officer, Chief Sales Officer, and Executive Director, along with a full complement of clinical and administrative personnel. The founder serves in an advisory role, with day-to-day operations fully delegated to the management team, ensuring continuity and a smooth transition for a buyer.
Asking Price
The asking price for this opportunity is $80 million.
